Sentences with phrase «diabetic retinopathy in»

Dr. Rotimi's lab has shown that a polymorphism in the endothelial nitric oxide gene is associated with diabetic retinopathy in Africans.
Competitions that are currently under way include one sponsored by the California Healthcare Foundation on identifying diabetic retinopathy in eye images and using U.S. Forest Service data to predict types of tree cover for a given location.
Researchers compared how well IDx - DR detected diabetic retinopathy in more than 800 U.S. patients with diagnoses made by three human specialists.
Artificial intelligence for automated detection of diabetic retinopathy in primary care.

Not exact matches

In turn, this could help increase the likelihood of catching diabetic retinopathy early.
This complication is called diabetic retinopathy (DR), when blood vessels are progressively damaged in the retina.
As it stands, three quarters of a million people with diabetes in England are at risk of losing their sight because they are not being screened for diabetic retinopathy.
2 Retinal screening with a digital camera is used to spot signs of retinopathy, a diabetic complication that occurs when blood vessels in the retina of the eye become blocked, leaky or grow haphazardly.
More than half a million ¹ people with diabetes in England are at increased risk of blindness because they have not received retinal screening2, an essential annual check which tests for eye disease (diabetic retinopathy).
According to the World Health Organization (WHO), diabetic retinopathy is the leading cause of blindness in adults of working age, and its incidence is showing an upward trend.
Between 12,000 and 24,000 people in the United States lose their vision to diabetic retinopathy each year, but the condition can be treated if caught early.
The prevalence of Type 1 and Type 2 diabetes in the United States is 9.3 percent and expected to increase, along with complications associated with diabetes that include diabetic retinopathy, the leading cause of new cases of blindness among adults ages 20 to 74 in the United States.
The study could also lead to better treatment for diabetic retinopathy, which currently requires multiple, invasive procedures that aren't always effective in the long term.
The study, published online ahead of print in The Journal of Clinical Investigation, has implications for treating diseases such as diabetic retinopathy and age - related macular degeneration — the leading causes of vision loss in adults.
This is the case with age - related macular degeneration — a «wet» version of which causes vision loss in the center of the eye — and diabetic retinopathyin which some people with diabetes develop blurry or patchy vision.
Yonju Ha, a lead author of this article, said that further studies on this receptor and its role in white blood cell recruitment following tissue injury may aid in the development of new interventions for diseases associated with nerve injury, such as TON, stroke, diabetic retinopathy and glaucoma.
An unexpected finding was that many of the innate immunity pathways that were active in the late stages of these inherited blinding diseases were the same as those that are associated with more common vision disorders including diabetic retinopathy and age - related macular degeneration, or AMD.
About 750,000 Americans with diabetic retinopathy have diabetic macular edema (DME) in which fluid leaks into the macula, the area of the retina used when looking straight ahead.
«We were surprised to find so many similarities between these two diseases, but most striking was that some of these common signatures are shared with other conditions like diabetic retinopathy and age - related macular degeneration,» said William A. Beltran, senior author on the study, an associate professor of ophthalmology in Penn Vet's Department of Clinical Sciences and Advanced Medicine and director of the Division of Experimental Retinal Therapies.
«Our findings are important because improved understanding of the pathogenesis of diabetic retinopathy is important in order to identify new treatments.
Corresponding Author Doctor Abd Tahrani, of the University of Birmingham's Institute of Metabolism and Systems Research, said: «Despite improvements in glucose, blood pressure and lipid levels, diabetic retinopathy remains very common.
The results showed that diabetic retinopathy prevalence was higher in patients with OSA (42.9 %) compared to those without OSA (24.1 %).
Meanwhile, diabetic retinopathy - the most common form of diabetic eye disease — affects between 40 and 50 per cent of patients with diabetes and is a leading cause of blindness in the Western world.
One in 10 Americans have diabetes, putting them at heightened risk for visual impairment due to the eye disease diabetic retinopathy.
The findings, published in JAMA Ophthalmology, point to critical interventions in the prevention and treatment of blinding eye diseases, such as age - related macular degeneration and diabetic retinopathy (DR), among Chinese Americans.
OCTs are a non-invasive scan commonly used in clinics to diagnose diabetic retinopathy and macular degeneration.
«Our study presents an unexpected finding that the connections between cells in the retinal blood vessels contain unusual, long - chain lipids that may keep vessels from leaking, possibly preventing diabetic retinopathy from occurring,» said Julia Busik, lead author of the study and a physiology professor.
Until now, it hadn't been clear whether strict control of blood sugar and fats, or lipids, could still deter retinopathy in patients who had been diabetic for as long as a decade.
The study, from researchers involved with the nationwide SEARCH for Diabetes in Youth Study, looked at five health complications and co-morbidities of diabetes, including: retinopathy (eye disease), diabetic kidney disease, peripheral neuropathy (altered sensation in the feet), arterial stiffness and high blood pressure.
Years of high blood sugar can damage blood vessels in the retina, leading to diabetic retinopathy.
The initial application to diabetic retinopathy shows proof - of - principle in a very important disease, but the approach can be adapted to other powerful drugs and diseases where localized activity is needed.»
In fact, many forms of blindness result from illnesses that injure the retina, including macular degeneration, glaucoma and diabetic retinopathy.
In addition, there was a positive relationship between increased intraocular levels of a soluble form of the (pro) renin receptor and monocyte chemotactic protein - 1, a known inflammatory mediator in uveitis as well as in diabetic retinopathIn addition, there was a positive relationship between increased intraocular levels of a soluble form of the (pro) renin receptor and monocyte chemotactic protein - 1, a known inflammatory mediator in uveitis as well as in diabetic retinopathin uveitis as well as in diabetic retinopathin diabetic retinopathy.
Scientists have developed a new RNA interference (RNAi) therapeutic agent that safely blocked ocular inflammation in mice, potentially making it a new treatment for human uveitis and diabetic retinopathy.
Other authors on the diabetic retinopathy study are Stephen A. Burns, professor in the IU School of Optometry, and John Gens, assistant scientist, and Xiao Fu, graduate student, of the IU Biocomplexity Institute.
Inflammation plays a central role in vision - threatening eye diseases such as age - related macular degeneration and diabetic retinopathy.
A common cause of vision loss in people with diabetes, diabetic retinopathy is responsible for 1 percent of all blindness worldwide and is a leading cause of blindness in American adults.
Therefore, drugs targeting the RAPS may result in beneficial effects on various vascular disorders, including uveitis and diabetic retinopathy.
Harris et al. [2] also provided evidence of the presence of retinal hypoxia in the early stages of diabetes by showing that contrast sensitivity was improved when patients with early diabetic retinopathy were made hyperoxic.
In most cases, hypoxia is caused by either a dysfunction of the retinal vasculature, as in diabetic retinopathy and retinal artery and vein occlusions, or it is due to a mismatch between nutrient supply and demand, as in the case of a retinal detachment, where the retina is separated too far from the choroid to receive sufficient oxygeIn most cases, hypoxia is caused by either a dysfunction of the retinal vasculature, as in diabetic retinopathy and retinal artery and vein occlusions, or it is due to a mismatch between nutrient supply and demand, as in the case of a retinal detachment, where the retina is separated too far from the choroid to receive sufficient oxygein diabetic retinopathy and retinal artery and vein occlusions, or it is due to a mismatch between nutrient supply and demand, as in the case of a retinal detachment, where the retina is separated too far from the choroid to receive sufficient oxygein the case of a retinal detachment, where the retina is separated too far from the choroid to receive sufficient oxygen.
Along with colleagues George L. King, M.D., and Edward P. Feener, Ph.D., at the Joslin Diabetes Center, Dr. Aiello also contributed to the first evidence that protein kinase C - beta (PKC - beta) and plasma kallikrein are involved in vascular leakage in diabetic retinopathy.
Development of this drug was based on earlier work by Dr. Feener's lab, which showed that activation of PKal can induce retinal edema in experimental models of diabetic retinopathy.
The pioneering work of Dr. Aiello helped demonstrate the role of vascular endothelial growth factor (VEGF) in diabetic retinopathy and other retinal disorders, as well as the therapeutic potential of VEGF inhibitors in these conditions.
In addition to developing therapies for AMD, my laboratory develops therapies for retinitis pigmentosa, diabetic retinopathy and more recently, uveitis; and I have significant interest in developing technologies that can translate basic laboratory research into the cliniIn addition to developing therapies for AMD, my laboratory develops therapies for retinitis pigmentosa, diabetic retinopathy and more recently, uveitis; and I have significant interest in developing technologies that can translate basic laboratory research into the cliniin developing technologies that can translate basic laboratory research into the clinic.
In the study, Joslin researchers examined samples of vitreous (eyeball) fluid from 61 patients with diabetic retinopathy or control group with a non-diabetic form of macular damage.
Dr. Aiello is recognized internationally for his leadership in diabetic retinopathy research.
Summary: Use of eye injections of drugs aimed at slowing the growth of abnormal blood vessels in the eye is becoming more common for the treatment of individuals with many eye problems including macular degeneration, diabetic retinopathy and retinal artery or vein blockage.
SALT LAKE CITY — Two major eye diseases and leading causes of blindness — age - related macular degeneration and diabetic retinopathy — can be reversed or even prevented by drugs that activate a protein found in...
Lead author of the study is physiology professor Julia Busik and she says: «Our study presents an unexpected finding that the connections between cells in the retinal blood vessels contain unusual, long - chain lipids that may keep vessels from leaking, possibly preventing diabetic retinopathy from occurring.»
A new study published in the journal Science Translational Medicine reveals new steps in the development of diabetic retinopathy and shows that they can be prevented using targeted drugs.
a b c d e f g h i j k l m n o p q r s t u v w x y z